Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Takeda Pharma says EDARBI now available in US pharmacies for patients with hypertension
pharmabiz
Saturday, April 16, 2011 - 1:42pm
tags:
Edarbi, Takeda, ARBs, antihypertensives
Is Boston Scientific's Stock Cheap by the Numbers?
Motley Fool
Saturday, April 16, 2011 - 1:28pm
tags:
Boston Scientific
Abbott Agreed to Pay $52 Million to Resolve Aids Drug Case
Bloomberg
Saturday, April 16, 2011 - 1:28pm
tags:
Norvir, HIV
Dark Clouds Lift Over Pharma Dispute
Motley Fool
Saturday, April 16, 2011 - 1:27pm
tags:
Merck, Schering Plough, JNJ, Remicade, Simponi
Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic Insufficiency
Yahoo/PR NewsWire
Saturday, April 16, 2011 - 1:20pm
tags:
Eli Lilly, liprotamase, exocrine pancreatic insufficiency
Synthes shares jump on rumor J&J deal in the works
Yahoo/AP
Saturday, April 16, 2011 - 1:18pm
tags:
Synthes, JNJ
Earnings Preview: J&J to report 1Q earnings
Yahoo/AP
Saturday, April 16, 2011 - 1:18pm
tags:
JNJ
ARCA biopharma Licenses Exclusive Worldwide Rights to Bucindolol Genetic Markers
Yahoo/BusinessWire
Saturday, April 16, 2011 - 1:15pm
tags:
ARCA biopharma, bucindolol, Gencaro
Biogen Test Finds Tysabri Patients With 1% Risk of Getting Brain Disease
Bloomberg
Saturday, April 16, 2011 - 1:12pm
tags:
Biogen Idec, Tysabri, progressive multifocal leukoencephalopathy, multiple sclerosis
Initiating Affymetrix at Neutral
Yahoo/Zacks
Saturday, April 16, 2011 - 1:11pm
tags:
Affymetrix
Corcept Therapeutics Announces NDA Submitted to the FDA for the Use of CORLUX in Cushing's Syndrome
Yahoo/MarketWire
Saturday, April 16, 2011 - 1:10pm
tags:
Corcept Therapeutics, Corlux, Cushing's disease
Aedonas Meets Primary Outcome of Clinical Study and More
Seeking Alpha
Saturday, April 16, 2011 - 1:09pm
tags:
Aedonas, reaZin, Alzheimer's disease
Momenta's stock climbs on UBS coverage
bizjournals.com
Saturday, April 16, 2011 - 1:07pm
tags:
Momenta, Lovenox
InterMune ex-CEO Harkonen sentenced in Actimmune drug scandal Read more: InterMune ex-CEO Harkonen sentenced in Actimmune drug scandal
bizjournals.com
Saturday, April 16, 2011 - 12:21pm
tags:
InterMune, Actimmune, legal
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug
Motley Fool
Saturday, April 16, 2011 - 12:20pm
tags:
Amylin, Alkermes, diabetes, Eli Lilly, Bydureon
Advaxis: Collaboration with Wistar Institute Explores new Opportunity
Yahoo/Zacks
Saturday, April 16, 2011 - 12:19pm
tags:
Advaxis, fibroblast activation protein, cancer
Insulin patch developer Calibra raises $8.1M, including $1M in canceled debt Read more: Insulin patch developer Calibra raises $8.1M, including $1M in canceled debt
bizjournals.com
Saturday, April 16, 2011 - 12:18pm
tags:
Calibra, insulin patch, diabetes
[video] The Next Big Thing In Biotech: Earnings
TheStreet.com
Friday, April 15, 2011 - 11:31am
tags:
biotech, earnings, Amgen, Gilead Sciences, Biogen Idec, Alexion
Adeona Zinc Tab Fails to Aid Alzheimer's Patients
TheStreet.com
Friday, April 15, 2011 - 11:30am
tags:
Adeona, Alzheimer's disease, reaZin
Such A Deal! SuperGen & Its Growth Strategy
Pharmalot
Friday, April 15, 2011 - 11:28am
tags:
Supergen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.